1. Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. 2019; Systematic review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 139:e1144–61. DOI:
10.1161/CIR.0000000000000626.
Article
2. Havel RJ, Eder HA, Bragdon JH. 1955; The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1345–53. DOI:
10.1172/JCI103182. PMID:
13252080. PMCID:
PMC438705.
Article
4. Frost PH, Havel RJ. 1998; Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol. 81:26B–31B. DOI:
10.1016/S0002-9149(98)00034-4. PMID:
9526810.
Article
6. Martin SS, Blaha MJ, Elshazly MB, Brinton EA, Toth PP, McEvoy JW, et al. 2013; Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol. 62:732–9. DOI:
10.1016/j.jacc.2013.01.079. PMID:
23524048.
Article
7. Nauck M, Warnick GR, Rifai N. 2002; Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 48:236–54. DOI:
10.1093/clinchem/48.2.236. PMID:
11805004.
Article
8. Miki Y. 1999; A homogeneous assay for the selective measurement of LDL-cholesterol in serum. Enzymatic selective protection method. Clin Lab. 45:398–401.
10. Azimi V, Farnsworth CW, Roper SM. 2022; Comparison of the Friedewald equation with Martin and Sampson equations for estimating LDL cholesterol in hypertriglyceridemic adults. Clin Biochem. 108:1–4. DOI:
10.1016/j.clinbiochem.2022.07.005. PMID:
35905970.
Article